Brilinta and Tadalafil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Brilinta (ticagrelor) and Tadalafil (tadalafil). Common drug interactions include dermatitis atopic among females and acute myocardial infarction among males.
The phase IV clinical study analyzes what interactions people have when they take Brilinta and Tadalafil. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Brilinta?
Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.
What is Tadalafil?
Tadalafil has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 25,549 Tadalafil users. Check the latest studies of Tadalafil.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
19 people who take Brilinta and Tadalafil together, and have interactions are studied.

What are the common drug interactions of Brilinta and Tadalafil, by gender? *:
female:
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Diarrhoea
- Loss of consciousness
- Lower limb fracture
- Pain
- Pruritus (severe itching of the skin)
- Skin haemorrhage (bleeding into skin)
male:
- Acute myocardial infarction (acute heart attack)
- Arthralgia (joint pain)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Localised infection (infection at the single location)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Mood swings (an extreme or rapid change in mood)
- Pancreatitis (inflammation of pancreas)
- Pancreatitis acute (sudden inflammation of pancreas)
- Cough
- Hypotension (abnormally low blood pressure)
What are the common drug interactions of Brilinta and Tadalafil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Acute myocardial infarction (acute heart attack)
- Arthralgia (joint pain)
- Cough
- Hypotension (abnormally low blood pressure)
- Carotid artery aneurysm (a bulging or ballooning in the wall of a blood vessel)
60+:
- Death
- Type 2 diabetes mellitus
- Pain
- Pancreatitis acute (sudden inflammation of pancreas)
- Pruritus (severe itching of the skin)
- Skin haemorrhage (bleeding into skin)
- Deafness
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Diarrhoea
- Emergency care
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 26.32%
- Polyarthritis (arthritis which involves 5 or more joints simultaneously): 3 people, 15.79%
- Type 2 Diabetes: 2 people, 10.53%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 10.53%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 10.53%
- Drowsiness: 2 people, 10.53%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 10.53%
- Heart Rate Decreased: 1 person, 5.26%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.26%
- Diabetes: 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Brilinta and Tadalafil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Brilinta and Tadalafil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Brilinta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tadalafil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Brilinta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tadalafil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ticagrelor and tadalafil (the active ingredients of Brilinta and Tadalafil, respectively), and Brilinta and Tadalafil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zithromax and Ropinirole Hydrochloride - 14 seconds ago
- Fluconazole and Pancytopenia for Women aged 20-29 - 23 seconds ago
- Could Cetirizine Hydrochloride cause Tension Headache? - 30 seconds ago
- Hydroxyzine and Hallucinations Aggravated for Women aged 20-29 - 44 seconds ago
- Drug interactions of Sudafed 12 Hour and Carboplatin - 50 seconds ago
- Could Sodium Chloride cause Dyspnea At Rest? - a minute ago
- Could Multivitamin cause Heart Palpitations? - a minute ago
- Cisplatin and Afatinib drug interactions for women aged 60+ - a minute ago
- Could Lisinopril cause Euphoric Mood? - a minute ago
- Pneumonia and Body Height Decreased - a minute ago